A Randomized Controlled Trial of Qigong Exercise on Fatigue Symptoms, Functioning, and Telomerase Activity in Persons with Chronic Fatigue or Chronic Fatigue Syndrome by Rainbow T. H. Ho et al.
ORIGINAL ARTICLE
A Randomized Controlled Trial of Qigong Exercise on Fatigue
Symptoms, Functioning, and Telomerase Activity in Persons
with Chronic Fatigue or Chronic Fatigue Syndrome
Rainbow T. H. Ho, Ph.D. & Jessie S. M. Chan, M.P.H. &
Chong-Wen Wang, Ph.D. & Benson W. M. Lau, Ph.D. &
Kwok Fai So, Ph.D. & Li Ping Yuen, B.C.M. &
Jonathan S. T. Sham, M.D. & Cecilia L. W. Chan, Ph.D.
Published online: 27 June 2012
Introduction
Chronic fatigue is a common complaint in both primary care
settings and in the general population. According to criteria
established in the USA [1] and Canada [2], chronic fatigue
is severe fatigue that persists or relapses for at least
6 months, while chronic fatigue syndrome, which is distin-
guished from chronic fatigue by severity and chronicity [3],
is defined as “medically unexplained” fatigue lasting for six
or more months. In recent years, researchers have paid
increasing attention to chronic fatigue and chronic fatigue
syndrome. The reported rates of chronic fatigue have ranged
from 0.037 to 18.3 % in the general adult population [3–6].
The reported rates of chronic fatigue syndrome, however,
have ranged between 0.007 and 2.8 % of the general adult
population and between 0.006 and 3 % of patients seeking
medical care [4, 7–9]. A population-based study in Hong
Kong reported a point prevalence of chronic fatigue among
adults as 10.7 % [3], while chronic fatigue syndrome was
identified in 3 % of the local adult patients [10]. Chronic
fatigue symptoms were reported as particularly common in
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Abstract
Background Chronic fatigue is common in the general
population. Complementary therapies are often used by
patients with chronic fatigue or chronic fatigue syndrome
to manage their symptoms.
Purpose This study aimed to assess the effect of a 4-month
qigong intervention program among patients with chronic
fatigue or chronic fatigue syndrome.
Methods Sixty-four participants were randomly assigned to
either an intervention group or a wait list control group.
Outcome measures included fatigue symptoms, physical
functioning, mental functioning, and telomerase activity.
Results Fatigue symptoms and mental functioning were
significantly improved in the qigong group compared to
controls. Telomerase activity increased in the qigong group
from 0.102 to 0.178 arbitrary units (p<0.05). The change
was statistically significant when compared to the control
group (p<0.05).
Conclusion Qigong exercise may be used as an alternative
and complementary therapy or rehabilitative program for
chronic fatigue and chronic fatigue syndrome.
Keywords Qigong . Exercise .Chronicfatigue .Telomerase .
Randomized controlled trial
women [6]. Given the unfavorable mental and physical
outcomes of chronic fatigue and chronic fatigue syndrome
that affect daily functioning, the burden of these conditions
on healthcare and the economy should not be underestimated.
Though the etiopathogenesis of chronic fatigue syndrome
is not yet well understood, the multifactorial disease path-
ways and the biopsychosocial model have been widely
accepted as explanations for its complex symptoms and
underlying mechanisms [11–13]. The inflammatory, im-
mune, oxidative, and nitrosative pathways were suggested
to induce a series of immunological and biological conse-
quences that further impair physical and psychological func-
tioning. According to this model, chronic fatigue symptoms
develop through a developmental and cumulative process
that involves different psychobiological factors contributing
to triggering, predisposing, and maintaining stages. Among
those factors, stress has been increasingly recognized as
playing an important role in both the etiology and patho-
physiology of chronic fatigue and chronic fatigue syndrome
[14–16]. Clinically, psychiatric disorders are common
among patients with chronic fatigue or chronic fatigue syn-
drome [3]. Research has demonstrated that both the occur-
rence of recent stressful life events and chronic stress levels
appear to be increased in patients with chronic fatigue or
chronic fatigue syndrome [17–20].
Because the pathophysiology of chronic fatigue and
chronic fatigue syndrome remains inchoate, current treat-
ment modalities mainly seek to alleviate symptoms [14]. To
date, there are controversies regarding appropriate strategies
for the treatment or management of chronic fatigue and
chronic fatigue syndrome. Because western treatments and
medications are often associated with limited clinical bene-
fits [21] and possible undesirable side effects [22], comple-
mentary and alternative therapies are often used by
individuals with chronic fatigue or chronic fatigue syn-
drome to manage their symptoms [23, 24]. From the per-
spective of traditional Chinese medicine, chronic fatigue
and chronic fatigue syndrome are caused by blood stasis
due to qi (vital energy) deficiency and/or emotional con-
strain; therefore, stimulation of the blood and qi circulation
(Xing Qi Huo Xue,行氣活血) is the core treatment strategy
for chronic fatigue and chronic fatigue syndrome [22, 25].
Qigong, a mind–body exercise within the paradigm of
traditional Chinese medicine, is practiced by a large number
of people in Chinese communities. It aims to achieve a
harmonious flow of energy (qi) in the body through gentle
movements that integrate body, mind, and spirit, to improve
physical fitness, overall well-being, and longevity. Several
randomized controlled trials of qigong exercise have dem-
onstrated health benefits for patients with chronic neck pain
[26, 27], knee osteoarthritis [28], fibromyalgia [29], chronic
obstructive pulmonary disease [30], or cancer [31]. Qigong
exercise has also been applied in two pilot studies for the
treatment of chronic fatigue and chronic fatigue syndrome
[32, 33], and desirable effects on symptoms and physical
and mental functioning have been suggested in these stud-
ies. The beneficial effects of qigong exercise for chronic
fatigue and chronic fatigue syndrome should be further
tested in large-scale randomized controlled trials.
To date, little is known about the effects of qigong
exercise on telomeres and telomerase. Telomeres are protec-
tive DNA sequences at the ends of linear chromosomes that
ensure chromosomal stability. They shorten with each cell
division or under conditions of oxidative stress [34, 35].
Telomere length has been used as a “psychobiomarker”
linking stress and disease [36]. Shortened telomere in
humans is emerging as a marker of disease risk and progres-
sion, and premature mortality [37–39]. Telomere shortening
can be counteracted by the cellular enzyme telomerase.
Telomerase activity plays an essential role in cell survival
by extending telomere length and protecting the chromo-
somes, which promotes cell growth and longevity. Previous
studies have suggested that detectable changes in telomere
length cannot be detected over a short period of time and at
least 1 year may be needed [40]. Thus, testing telomerase
activity is an optimal alternative and has been used in some
studies. Previous studies have shown that both shortened
telomere and lower telomerase activity are associated with
chronic psychological distress such as chronic fatigue syn-
drome [40–43]. Recent findings suggest that telomerase
activity may be improved by intensive meditation training
[44], yogic meditation [45], physical exercise [46, 47], or
comprehensive lifestyle changes [40]. However, little is
known about whether telomerase activity can be improved
by other forms of mind–body intervention, such as qigong
exercise, which is considered a holistic health practice pro-
moting physical and mental well-being as well as longevity.
Thus, the primary aim of this randomized controlled trial
is to evaluate the effects of qigong exercise on fatigue-
related symptoms and physical and mental functioning in
patients with chronic fatigue or chronic fatigue syndrome.
The secondary aim of this trial is to evaluate the effect of
qigong exercise on telomerase activity, drawing on its po-
tential impact on stress-related damage at the cellular level.
We hypothesized that qigong exercise would lead to positive
improvements in fatigue-related symptoms and functioning
in persons with chronic fatigue or chronic fatigue syndrome
and would result in increased telomerase activity.
Methods
Participants
Participants in this study were recruited from communities
through advertising online and in local newspapers, as it is
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generally rare for patients with chronic fatigue or chronic
fatigue syndrome alone to stay in public hospitals, and there
is no register of or self-help organization for patients with
chronic fatigue syndrome in Hong Kong. Eligible partici-
pants were adults aged 18 to 55 years (those older than
55 years were excluded due to high possibility of chronic
illness) who were available at all testing points, were recep-
tive to random allocation, and met the United States Centers
for Disease Control (CDC) inclusion criteria for chronic
fatigue syndrome [1], which are the most widely used in
the field. According to these criteria, individuals with chron-
ic fatigue or chronic fatigue syndrome are those with fatigue
that has persisted or relapsed for six or more months and is
accompanied by four or more of the following eight distinc-
tive symptoms: impaired memory or concentration capacity,
post-exertional malaise, sleep problems, muscle pain, ar-
thralgia, headache, recurrent sore throat, and tender cervical
or axillary lymph nodes. To minimize the impact of chronic
illnesses as much as possible, those with any diagnosed
medical conditions that might explain the presence of chron-
ic fatigue were excluded. Examples of these conditions
included cancer, hypothyroidism, sleep apnea, narcolepsy,
hepatitis B or C virus infection, substance abuse, and mental
disorders (e.g., major depressive disorder, bipolar affective
disorders, schizophrenia), and severe obesity. We also ex-
cluded persons who had participated in qigong training
within the previous 6 months and those with serious medical
conditions that might limit their participation. All partici-
pants provided written informed consent. Ethical approval
was obtained from the Institutional Review Board of the
University of Hong Kong/Queen Mary Hospital/Hong Kong
Hospital Authority West Cluster.
The study was advertised in the media, and 1,441
adults volunteered to fill in an online screening question-
naire. Two hundred and thirty-six subjects met the inclu-
sion criterion, of which 82 subjects were excluded
because they could not be contacted or were unavailable
for the qigong training. Of the 154 subjects who were
willing to take part in the study, 84 were excluded because
they were unavailable for the blood sample collection at
the baseline measurement (there was no significant differ-
ence in demographic characteristics and reported fatigue
symptoms between this group of subjects and those in-
cluded). Consequently, 70 subjects were included in this
study, but 6 dropped out before qigong training (2 in the
intervention group and 4 in the control group). Thus, the
analyses were based on a final sample of 64 participants
(33 in the intervention group and 31 in the control group).
The recruitment target of 30 participants per group was
calculated on the basis of a similar number of referred
subjects in two previous studies on chronic fatigue syn-
drome [48, 49]. A trial with 60 participants would provide
a power of 80 % to detect a 0.72 standardized difference
at a two-sided significance level of 5 %. The flow chart of
the selection of participants is presented in Fig. 1.
Study Design and Procedure
This study was a randomized controlled clinical trial with
repeated measures, which was conducted between October
2010 and March 2011. Each potential participant was required
to complete an online screening questionnaire and was evalu-
ated for eligibility by a pair of investigators with any discrep-
ancies being resolved by discussion. Eligible participants were
required to complete an additional questionnaire to measure the
severity of their chronic fatigue symptoms and physical and
mental functioning before intervention and at follow-ups. Fol-
lowing the online screening, the participants completed the
baseline measures and gave a blood sample after having signed
the written informed consent form. Each participant was
assigned an order number before the baseline assessment. They
were then randomly assigned to either the intervention group or
a wait list control group according to the order numbers. For
allocation of the participants, a computer-generated list of
random numbers was used. Blinding the participants to the
allocation was not possible due to the nature of intervention.
The intervention program lasted 4 months, with group qigong
training for 5 weeks followed by home-based qigong exercise
for 12 weeks in the intervention group. Primary outcomes were
self-perceived fatigue symptoms severity and physical and
mental functioning, while secondary outcome was telomerase
activity in peripheral blood mononuclear cells. Data for the
subjective outcome measures were collected from both the
intervention group and control group at three time points: pre-
intervention (T0, baseline), post-training (T1, 5 weeks after),
and post-intervention (T2, 4 months after). Blood samples from
the participants were collected at two time points: pre-
intervention (T0) and post-intervention (T2).
Intervention
Participants assigned to the intervention group received
group qigong exercise training (Wu Xing Ping Heng Gong,
五行平衡功) twice a week for five consecutive weeks,
followed by home-based qigong exercise for 12 weeks.
Each session of qigong exercise training lasted 2 h, with a
brief introduction to the basic theories of traditional Chinese
medicine or educational session on the physiology of mind–
body connections (30–40 min), followed by mindful medi-
tation for relaxation and mind concentration and then gentle
movement or body stretching in standing postures to facil-
itate a harmonious flow of qi along the energy channels
(20 min). Lastly, a 1-h session of qigong exercise training
was delivered by an experienced Daoist qigong master
(Yuen L.P.) with more than 20 years of experience in qigong
practice as well as a background in traditional Chinese
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medicine. During the 4-month intervention program, all
participants in the intervention group were required to en-
gage in qigong exercise 30 min every day at home. To
assess home exercise, they were required to report the fre-
quency and duration as well as adverse effects of the self-
practice at home at the end of the program. No adverse
effects were reported. Participants assigned to the control
group were advised to undertake normal activities but were
asked to refrain from joining any outside qigong training
class. No participants in the control group joined an outside
qigong class as qigong exercise training was provided to
them after the final outcome measurement.
Measures
Screening Measures
Each potential participant was required to complete an online
screening questionnaire that elicited the following: (1) demo-
graphic information consisting of age, gender, employment
status, education level, marital status, religion, and the number
of family members living together with the participant; (2) an
item to indicate whether or not fatigue symptoms persisted or
relapsed for six or more months, and a list of the eight
distinctive chronic fatigue symptoms recommended in the
CDC inclusion criteria for chronic fatigue syndrome [1]; (3)
a checklist of medical history based on the CDC exclusion
criteria for chronic fatigue syndrome [1]; and (4) reported
lifestyle in the previous 6 months, including details on exer-
cise, smoking, and alcohol consumption.
Chalder’s Fatigue Scale
The severity of chronic fatigue was assessed by using
Chalder’s Fatigue Scale [50], which was developed to mea-
sure the severity of fatigue over the previous 6 months. The
scale consists of 14 items for evaluating two dimensions of
chronic fatigue: physical fatigue (8 items) and mental fa-
tigue (6 items) on a five-point Likert scale (none, better than
usual, no more than usual, worse than usual, much worse
than usual). The five responses are scored from 0–4. The
subscale scores are equal to the summed scores for the
Fig. 1 Flow chart of the
selection of participants in the
study
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physical fatigue and mental fatigue items. The total fatigue
score is obtained by summing all of the items [50]. The scale
was found to be both reliable (r00.86 for physical fatigue, and
r00.85 for mental fatigue) and valid (Cronbach's
α00.89). A recent study of the Chinese version of
Chalder’s Fatigue Scale also supported the notion of a
two-factor structure in the community sample, and the
internal consistency of the Chinese version was good
(α00.863) [51].
Medical Outcomes Study 12-Item Short-Form Health Survey
Physical functioning and mental functioning were assessed
by the Chinese version of the Medical Outcomes Study 12-
Item Short-Form Health Survey [52, 53]. The 12 items are
classified into two subscales to measure the two dimensions
of health: physical functioning (6 items) and mental func-
tioning (6 items). Accordingly, two summary scores are
yielded. Each subscale is scored on a 0–100 scale in which
100 indicates the best possible score and 0 indicates the
worst.
Measurement of Telomerase Activity
For each participant, 3 ml of peripheral blood was collected
in heparinized tubes. The peripheral blood mononuclear
cells were isolated from each blood sample using Ficoll-
Paque PLUS (GE Healthcare). In brief, 1 ml of blood
sample was layered on 750 μl of Ficoll-Paque, and subse-
quently centrifuged at 400×g for 20 min at room tempera-
ture. The upper plasma layer was then removed, and the
monocyte layer was collected immediately following centri-
fugation. The extracts were stored at −80 °C until further
processing. Telomerase activity was tested by a commer-
cially available kit TeloTAGGG telomerase PCR ELISA
(Roche) according to the protocol. In brief, 10 μl of mono-
nuclear cells isolated were lysed in 200 μl of lysis buffer,
and 3 μl of the obtained protein extract was used for the
subsequent telomerase-catalyzed primer elongation and
PCR reaction. Biotin-labeled primers were used in the
PCR reaction, then 5 μl of the PCR product was denatured,
hybridized to digoxigenin-labeled probes, and immobilized
to streptavidin-coated wells. Finally, the digoxigenin-
labeled products were visualized by a peroxidase-
conjugated anti-digoxigenin antibody and tetramethyl ben-
zidine acting as a peroxidase substrate. The level of telo-
merase activity is in proportion to the colorimetric measures.
The values were normalized to the positive control provided
in the ELISA kit, which is in a relative manner. For each
participant, telomerase activity in the peripheral blood
mononuclear cells was assayed at pre-intervention and at
the end of the 4-month intervention. The blood samples
were collected in an identical manner, at the same time of
day, and at the same location, and were treated identically at
all steps. The group allocation was blinded for laboratory
technicians.
Statistical Analysis
Continuous data were summarized by means and standard
deviations, and categorical data were summarized by fre-
quency. Differences at baseline for the demographic infor-
mation, lifestyles, and reported fatigue symptoms between
the two groups were compared using a chi-squared test for
categorical data and a t test or pairwise t test for continuous
data. The intragroup differences between different time
points for each outcome measure were compared using a
pairwise t test. Cohen’s d statistic was also calculated to
determine effect size for each outcome. Repeated measures
analyses of covariance (ANCOVA) were then performed to
test the interaction effect of time and group for each out-
come, adjusting for two fatigue symptoms (muscle pain, and
tender cervical or axillary lymph nodes). Effects were eval-
uated on an intention-to-treat basis, and the missing values
were substituted by way of mean imputation for each out-
come measure [54]. All data analysis was conducted with
SPSS (version 18.0, SPSS Inc., Chicago, IL). A p value less
than 0.05 was considered as statistically significant.
Results
Demographic Characteristics and Lifestyles at Baseline
Table 1 shows the baseline data for the demographic char-
acteristics, lifestyles, and self-reported chronic fatigue
symptoms of the intervention group and the control group.
The mean ages were 42.1 years (range 23–52) in the inter-
vention group and 42.5 years (range 29–51) in the control
group, respectively. More than three quarters of participants
were female (75.8 and 83.9 % in the two groups, respec-
tively). As shown in the table, baseline characteristics were
reasonably well balanced between the two groups. There
were no significant differences in lifestyles and the number
of chronic fatigue symptoms between the two groups, apart
from a just significant intergroup difference in the two types
of fatigue symptoms (muscle pain, and tender cervical or
axillary lymph nodes, p<0.05).
Twenty-seven participants (81.8 %) in the intervention
group and 25 (80.6 %) in the control group completed the 4-
month program. Six participants in each group withdrew
from the study (Fig. 1). Three additional participants in the
intervention group and one additional participant in the
control group did not fill in the questionnaire but provided
a blood sample for telomerase activity testing at the end of
the intervention program.
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The Efficacy of Intervention
Table 2 shows the intragroup and intergroup differences of
the subjective outcome measures, including the total fatigue
score, physical fatigue score, mental fatigue score, physical
functioning score, and mental functioning score. Compared to
baseline values, the total fatigue score (p<0.001, d0−1.5),
physical fatigue score (p<0.001, d0−1.9), mental fatigue
score (p00.001, d0−0.9), and mental functioning score
(p<0.001, d01.3) were significantly improved in the
intervention group at 5 weeks, and the improvement
was maintained at 4 months. Only the physical func-
tioning score was not significantly changed in the inter-
vention group. In the control group, the total fatigue
score, physical fatigue score, and mental fatigue score
were also significantly improved at 5 weeks (p00.003,
d0−0.7; p00.001, d0−0.6; and p00.031, d0−0.6 re-
spectively) and at the end of the 4-month program
(p00.001, d0−1.0; p00.001, d0−0.9; and p<0.001,
d0−0.9 respectively). The physical functioning score
Table 1 Baseline characteristics, lifestyles, and chronic symptoms
Demographic Intervention (n033) Control (n031) pa
Mean (SD) N (%) Mean (SD) N (%)
Age (years) 42.1 (7.3) 42.5 (5.5) 0.849
Gender
Female 25 (75.8 %) 26 (83.9 %) 0.420
Education 0.326
Secondary or high school 13 (39.4 %) 16 (51.6 %)
College or above 20 (60.6 %) 15 (48.4 %)
Marital status 0.756
Unmarried 9 (27.3 %) 11 (35.5 %)
Married/cohabited 21 (63.6 %) 17 (54.8 %)
Divorced/separated 3 (9.1 %) 3 (9.7 %)
Employment 0.374
Full time 27 (81.8 %) 24 (77.4 %)
Part time 2 (6.1 %) 0
Housewife 3 (9.1 %) 6 (19.4 %)
Unemployed 1 (3.0 %) 1 (3.2 %)
Religion involvement
Yes 8 (24.2 %) 12 (38.7 %) 0.212
Number of family members living together 0.610
None 4 (12.1 %) 3 (9.7 %)
1–2 14 (42.4 %) 17 (54.8 %)
3 or more 15 (45.5 %) 11 (35.5 %)
Lifestyles
Doing exercise regularly 9 (27.3 %) 3 (9.7 %) 0.071
Smoking 1 (3.0 %) 2 (6.5 %) 0.518
Alcohol drinking 12 (36.4 %) 11 (35.5 %) 0.942
Fatigue symptoms (at least 6 months)
Impaired memory or concentration capacity 31 (93.9 %) 29 (93.5 %) 1.000
Post-exertional malaise 29 (87.9 %) 29 (93.5 %) 0.673
Sleep problems 32 (97.0 %) 30 (96.8 %) 1.000
Muscle pain 27 (81.8 %) 31 (100 %) 0.025
Arthralgia 24 (72.7 %) 23 (74.2 %) 0.894
Headache 21 (63.6 %) 23 (74.2 %) 0.362
Recurrent sore throat 18 (54.5 %) 17 (54.8 %) 0.981
Tender cervical or axillary lymph nodes 19 (57.6 %) 26 (83.9 %) 0.021
Average number of reported fatigue symptoms 6.1 (1.4) 6.7 (1.3) 0.072
a Chi-squared test for categorical variables and t test for continuous variables
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and the mental functioning score were not significantly im-
proved in the control group compared to baseline values.
As shown in Table 2, the difference in the change of each
outcome measure was examined with the time and group
interaction effect. Compared to the control group, the im-
provement in the total fatigue score [F(2, 120)012.93,
p<0.05], physical fatigue score [F(2, 120)020.09, p<0.01],
mental fatigue score [F(2, 120)04.60, p<0.05], and mental
functioning score [F(2, 120)07.60, p00.001] was significant
in the intervention group, whereas the changes in the physical
functioning score in the intervention group were not signifi-
cant [F(2, 120)00.69, p>0.05].
In Table 3, the telomerase activity at baseline and at the
end of the 4-month intervention program was compared
within and between the two groups. Compared to baseline
values, telomerase activity was significantly improved at the
end of the program in the intervention group (p00.033,
d00.52), but was not improved in the control group. The
change of telomerase activity in the intervention group was
statistically significant when compared to the control group,
as indicated by the interaction effect of time and group [F(2,
120)05.03, p<0.05].
Discussion
The results of the current study suggested that qigong exer-
cise improved fatigue symptoms for patients with chronic
fatigue or chronic fatigue syndrome, as indicated by the
significant change in the total fatigue score. This result
confirms the findings of an uncontrolled pilot study [32]
and a small-scale randomized controlled trial of qigong
exercise among patients with chronic fatigue syndrome
[33]. Our results further indicated that qigong exercise im-
proved physical fatigue symptoms more significantly than
mental fatigue symptoms. Given the nature of chronic fatigue
syndrome, these effects are understandable. Clinically, chron-
ic fatigue syndrome is also named myalgic encephalomyelitis.
Table 2 Intragroup and intergroup comparisons for subjective outcomes using repeated measures ANCOVA adjusting for fatigue symptoms
(muscle pain, tender cervical or axillary lymph nodes) at baseline
Baseline (T0) 5 weeks after (T1)a 4 months after (T2)a Time×group effect
Mean (SD) Mean (SD) Effect size (d) Mean (SD) Effect size (d) F p
Total fatigue score
Intervention group 39.9 (6.3) 26.3 (10.9)*** −1.5 21.6 (10.4)*** −2.1 12.93 0.000
Control group 39.7 (6.1) 34.8 (8.0)** −0.7 32.1 (8.8)*** −1.0
Physical fatigue score
Intervention group 25.0 (3.7) 15.2 (6.5)*** −1.9 12.9 (6.1)*** −2.4 20.09 0.000
Control group 24.7 (4.1) 21.8 (5.1)** −0.6 20.3 (5.7)*** −0.9
Mental fatigue score
Intervention group 14.9 (3.6) 11.1 (5.1)** −0.9 8.8 (4.6)*** −1.5 4.60 0.012
Control group 15.0 (3.2) 13.0 (3.9)* −0.6 11.9 (3.8)** −0.9
Physical functioning score
Intervention group 36.9 (7.2) 38.4 (6.1) 0.2 40.1 (6.9) 0.5 0.69 0.484
Control group 35.7 (7.1) 37.5 (8.1) 0.2 37.8 (5.6) 0.3
Mental functioning score
Intervention group 32.5 (10.7) 43.8 (6.9)** 1.3 42.7 (7.2)** 1.1 7.60 0.001
Control group 33.5 (9.6) 34.6 (9.6) 0.1 35.7 (9.5) 0.2
*p<0.05; **p<0.01; ***p<.0.001
a Compared with baseline values
Table 3 Intragroup and intergroup comparisons for telomerase activity using repeated measures ANCOVA adjusting for fatigue symptoms (muscle
pain, tender cervical, or axillary lymph nodes) at baseline
Telomerase activity (arbitrary unit) Baseline (T0) 4 months after (T2) Time×group effect
Mean (SD) Mean (SD) Effect size (d) F p
Intervention group 0.102 (0.051) 0.178 (0.201)* 0.52 5.03 0.029
Control group 0.089 (0.036) 0.104 (0.059) 0.31
*p<0.05
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Diagnosed chronic fatigue syndrome is actually a neurological
disorder, rather than a physical or mental problem alone.
Patients with chronic fatigue syndrome may be subject to
cognitive deterioration or impairment [55]. The mental fatigue
subscale of the Chalder’s Fatigue Scale includes items to
measure such dimensions as memory, concentration, problem
thinking, and difficulty finding correct words. These dimen-
sions are generally related to cognitive functioning. Generally,
it is more difficult to improve cognitive function than psycho-
logical well-being or mental health, including such dimen-
sions as energy and fatigue, body pain, and psychological
wellness as measured by the SF-12.
In the current study, the mental functioning score in the
qigong group was significantly improved compared to con-
trols. In a prior pilot randomized controlled trial on chronic
fatigue syndrome [33], bodily pain and mental health as
measured by SF-36 were significantly improved in the
qigong group compared to the baseline values, but the
difference in changes between the qigong group and the
control group was not significant, possibly due to the
study’s small sample size (n031). Our study indicated that
physical functioning measured by the physical health sub-
scale of SF-12 was not significantly improved in the qigong
group when compared to the controls. These results are
inconsistent with previous findings in an uncontrolled study
of qigong over 6 months among patients with chronic fa-
tigue syndrome [32], in which both physical functioning and
mental health as measured by the 116-item RAND Medical
Outcomes Study questionnaire were significantly improved.
Our results suggest that short-term qigong exercise may
improve fatigue symptoms but is not as effective in improv-
ing physical functioning for patients with chronic fatigue or
chronic fatigue syndrome. The improvement in physical
functioning may instead require long-term qigong exercise.
The current study is the first randomized controlled clin-
ical trial to measure the effect of qigong exercise on telo-
merase activity for individuals with chronic fatigue or
chronic fatigue syndrome. Findings from this study indicat-
ed that telomerase activity was significantly improved
among patients with chronic fatigue or chronic fatigue syn-
drome who received qigong exercise intervention over a 4-
month period, and the change in telomerase activity in the
qigong group was statistically significant when compared to
the control group. This result confirms the findings in pre-
vious studies on intensive meditative training [44], yogic
meditation [45], and comprehensive lifestyle changes [40].
In a pilot study among 30 adult patients with prostate
cancer, Ornish et al. [40] reported that 3 months of intensive
lifestyle changes increased telomerase activity in peripheral
blood mononuclear cells; however, there was not a usual
care control group in the study. In a recent randomized
controlled trial [44] of intensive meditation training among
60 healthy subjects, 46 (20 meditation retreat participants
and 26 controls) participated in telomerase activity assess-
ment and the results suggested greater telomerase activity in
the retreat participants than in the control group after
3 months of intensive meditation training, but there was no
baseline measure of telomerase activity in the study. There-
fore, generalization of the findings from these two studies is
limited. Most recently, Lavretsky and colleagues [45] con-
ducted a pilot randomized controlled trial to examine the
effect of 8 weeks of brief daily yogic meditation on immune
cell telomerase activity in family dementia caregivers with
mild depressive symptoms, and the results indicated a mar-
ginally significant difference (p00.05) in the change of
telomerase activity between the meditation group (n023)
and the relaxation control group (n016), probably due to
small size in the study. In the current randomized trial on the
basis of a justified sample of patients with chronic fatigue or
chronic fatigue syndrome, we examined the effect by com-
paring the intervention group with the control group and
adjusting for the baseline values. The result suggested a
statistically significant association between qigong exercise
and cellular telomerase activity.
As mentioned before, chronic fatigue and chronic fatigue
syndrome are often associated with a high level of perceived
stress and psychiatric disorders including depression, which
are common among patients with chronic fatigue or chronic
fatigue syndrome. Although a recent study [56] has sug-
gested increased telomerase activity in major depression,
explanations of the finding remain speculative and a number
of studies have suggested low telomerase activity in re-
sponse to psychological and oxidative stress as experienced
by patients with chronic fatigue or chronic fatigue syndrome
[43, 57, 58]. It is suggested that low telomerase activity
could result in shortened telomeres by limiting the replen-
ishment of impaired telomeres [59]. The underlying mech-
anism for the beneficial effects of qigong exercise as a
mind–body intervention on telomerase activity in the
current study may be explained in terms of two major
components of qigong exercise. During qigong exercise,
mindfulness, a key component of intensive meditative train-
ing, is often effectively cultivated. Thus, qigong exercise is
often used as a stress management strategy and is potentially
effective in enhancing cellular telomerase activity for
patients with chronic fatigue or chronic fatigue syndrome
through the reduction of the oxidative stress level [43, 60]
and regulating immune response [43, 44]. The hypothalam-
ic–pituitary–adrenal axis is an important pathway for these
effects [61]. Another underlying mechanism may be that
qigong exercise as a low-impact physical activity may in-
crease serum concentrations of insulin-like growth factor
(IGF) 1, which enhances telomerase activity and delays
cellular aging [46]. Even though a retrospective study [62]
among 69 healthy adults aged 50–70 years did not observe a
significant association between physical activity level and
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telomerase activity, a study in mice indicated that short-term
physical exercise (21 days) upregulated telomerase activity
to more than twice that of sedentary controls [46]. Another
study also indicated that physical exercise increased telo-
merase activity and neurogenesis in a mouse model of
schizophrenia [47].
Although the results of this study are promising, the
study has some limitations. One of major limitations is that
participants did not receive a medical examination from a
physician at the beginning of the study, so some of them
might have not fully met the CDC criteria for chronic
fatigue syndrome. Thus, the effects on telomerase activity
and subjective outcomes might have been confounded by
possible chronic disorders. Further studies should strictly
adhere to the CDC diagnostic criteria for chronic fatigue
syndrome. Another limitation is that the current study was
neither double blind nor included a control group that did
something equivalent to the controls, such as health educa-
tion class. Thus, the effects might be due to demand char-
acteristics, the Hawthorn effect, or possible placebo effect of
being in a group. Moreover, telomerase activity was not
tested during post-training; thus, attributing increased telo-
merase activity to qigong may be challenged given the
unknown reaction time for changing telomerase activity
after intervention. Furthermore, it is possible that other
factors besides qigong exercise such as meditation, physical
activity, body weight and life style change including diet,
and inflammation or infections [40, 43–47] might have
contributed to the increase in telomerase activity over a
period of 4 months. These confounders should be strictly
controlled in future studies. Finally, participants’ stress lev-
els were not measured before and after the invention, so the
mediating effect of decreased psychological stress in the
link between qigong exercise and the change in telomerase
activity could not be examined. Due to aforementioned
limitations, interpretation and generalization of the associa-
tion between qigong exercise and telomerase activity ob-
served in this study should be cautious. This finding needs
to be replicated in further carefully designed randomized
controlled trails, but it does raise the possibility of the
involvement of telomerase as an important biomarker for
mind–body interventions.
Conclusion
In conclusion, the results of the present study indicate that
qigong exercise may improve chronic fatigue symptoms and
mental functioning and result in increased telomerase activ-
ity for patients with chronic fatigue or chronic fatigue syn-
drome. The improvement in telomerase activity may be an
alternative pathway of the potential health benefits of
qigong exercise as a mind–body intervention. The results
suggest that qigong exercise as a modality of mind–body
therapy may be used as an alternative and complementary
therapy or rehabilitation program for chronic fatigue and
chronic fatigue syndrome.
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